Washington Post: Why aren’t we producing medications for looming global disease threats? Mel Spigelman, physician and president and chief executive of TB Alliance “…[A new Global Health Technologies Coalition] analysis reveals that over the past six years, [U.S.] taxpayer funding for global health research has been stagnant or declining. … Managing health threats through emergency…More
Kaiser Family Foundation: The U.S. Government and Global Tuberculosis This updated fact sheet discusses U.S. government global TB efforts and funding, global statistics related to the disease, and international goals to control and treat TB (3/20).
VOA News: WHO Rolls Out New Strategy to Wipe Out TB “As countries mark World TB Day on March 24, the World Health Organization (WHO) is rolling out a new strategy to end the global tuberculosis epidemic, calling for worldwide support to wipe out the disease over the next 20 years. Two previous strategies have…More
VOA News: Multi-Drug Resistant TB Harder to Spread Among Close Contacts “Incidences of multi-drug resistant tuberculosis (MDR-TB) are increasing, but British and Peruvian researchers are offering a glimmer of hope in the latest issue of PLOS Medicine. Caused by a bacterium that has evolved to become hard to kill with two or more mainstay antibiotics,…More
Center for Strategic & International Studies: Lessons from the Global Fund’s Reform In this report, Todd Summers, a senior adviser with the CSIS Global Health Policy Center, discusses reforms at the Global Fund to Fight AIDS, Tuberculosis and Malaria, and their lessons for other international organizations, including the WHO (6/24).
Global Health Technologies Coalition’s “Breakthroughs”: Research Roundup: a promising antimalarial and leishmaniasis vaccine, diagnostics for tuberculosis, and more Kat Kelley, GHTC’s senior program assistant, highlights recent news in global health research, including the development of an experimental antimalarial drug and a potential leishmaniasis vaccine, clinical trials for new tuberculosis diagnostic tests, and research into pediatric-appropriate…More
Times of San Diego: California and Mexico to Battle TB Problem Together “Public health officials from both sides of the border Friday signed an agreement for a joint effort to battle tuberculosis. … The agreement by health officials from San Diego and Imperial counties formalizes a comprehensive strategy to combat TB along the border, with…More
The Guardian: What is the Millennium Development Goal on HIV and malaria all about? “When the Millennium Development Goals (MDGs) were devised, AIDS, malaria, and tuberculosis killed approximately six million people each year. World leaders felt it was imperative to have a goal dedicated to tackling this deadly trio. … U.N. data indicate that the…More
New York Times: Letter to the Editor: Fighting the Tuberculosis Threat Thomas G. Evans, CEO of Advancing Tuberculosis Vaccines for the World “…[T]hroughout the world, nine million people are diagnosed with active TB every year and 1.5 million die — as many people die from HIV. … Decades of neglect have meant that a concerted…More
Devex: Mark Dybul: For the Global Fund, crisis led to opportunity “Sometimes it takes a crisis to return an organization to its ‘original principles.’ Mark Dybul, executive director of the Global Fund to Fight AIDS, Tuberculosis and Malaria, spoke with Devex about some of the challenges the organization faced — particularly around financial management —…More
Wall Street Journal: The Race for Faster Tuberculosis Tests “As U.S. health officials treat an Indian woman who entered the country with drug-resistant tuberculosis, scientists at Texas A&M Health Science Center are trying to develop faster and more accurate ways to diagnose the infectious disease. The timely detection of TB remains one of the greatest…More
Center for Global Health Policy’s “Science Speaks”: XDR-TB patient in U.S. highlights global reach of infectious disease Antigone Barton, senior editor and writer of “Science Speaks,” discusses extensively drug-resistant tuberculosis (XDR-TB) in light of the identification of a women with XDR-TB who traveled from India to the U.S. (6/10).
The Hill: TB: The forgotten global health threat Eric P. Goosby, U.N. secretary general’s special envoy on tuberculosis “As congressional committees debate the future of critical global health programs, they must not forget an all too neglected global health threat — tuberculosis (TB). … TB interventions are cost effective and save lives. There is a…More
Center for Strategic & International Studies’ “Smart Global Health”: South Africa’s Health Challenges: An Elephant in the Room CSIS Senior Associate Phil Nieburg discusses the challenges to preventing and treating tuberculosis in South Africa, writing, “…The South African government and its international partners need to work to address the structural and budgetary problems that inhibit…More
Center for Global Health Policy’s “Science Speaks”: Children, people with HIV, pregnant women, and others underserved by TB drug development present ethical imperative, opportunities for global disease approaches, authors say Antigone Barton, senior editor and writer of “Science Speaks,” discusses “an article [published] in a recently released Journal of Infectious Diseases supplement on tuberculosis drug…More
The recent adoption of the World Health Assembly Resolution 66.12 for neglected tropical diseases (NTDs) in May 2013 is an important turning point for advocacy regarding a number of endemic zoonotic infections, defined by the World Health Organization as the neglected zoonotic diseases (NZDs).
BMJ Blogs: Michel Kazatchkine: Tuberculosis and poverty in Europe Michel Kazatchkine, the U.N. secretary general’s special envoy for HIV/AIDS in Eastern Europe and Central Asia, discusses TB eradication efforts in Europe and the disease’s link to poverty, writing, “…Different pathways, including poor and crowded conditions of living, contribute to the strong positive correlation that exists…More